Status: Recruiting
Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II
The investigators wish to determine the time to disease progression for benign neurofibromas treated with Levulan Kerastick topical photosensitizer and red light photodynamic therapy (PDT) in patients with neurofibromatosis type 1 (NF1). The investigators also wish to measure tumor size for control and treatment tumors in order to gain insights into tumor growth rates.
Participants needed: 30
Trial details
Phase: Phase 2Age: 14-30Biological sex: AllType: InterventionalSponsor: Donald BaselUpdated: May 8, 2025Locations: 1
Eligibility criteria
Patient is 14 years or older. [+6]
Life expectancy less than 3 years. [+6]